Ubiquitech Software Corp (OTCMKTS:UBQU) posted its fourth quarter financial report. Revenues for the quarter came at around $1.23 million while for the year it stood at $4.514 million. The firm posted net income of $352,447 for the year closing November 30, 2017.
James Ballas, the CEO of Ubiquitech, expressed that they are extremely delighted to continue to advance and strengthen the firm. This marks the fourth successive year of revenue growth in double digits. The CannazALL brand remains to expand its presence in the buzzing Cannabidiol marketplace, and the firm continues to add inventive and new offerings to this product line. They look forward to their impending release of their CryptoBuy segment and the thrill that it will bring to the firm.
Earlier in the month of February, Ubiquitech Software, through its operating subsidiary unit HempLifeToday™, reported that it will be bringing new Cannabidiol Gummies to its expanding line of CannazALL™ Cannabidiol offerings derived from Hemp, as the firm is looking to venture into the lucrative edibles industry for full spectrum hemp offerings and Cannabidiol hemp products.
This will mark as the first new offering to release in 2018. The company has many other items to launch this year as well, and Ubiquitech will keep shareholders apprised of these additions as they yield results. These new Cannabidiol Gummies will most likely be launched in two versions with a 10mg and 5mg Cannabidiol potency. These low-dose types are perfect for kids, and can be given to them out multiple times a day instead of just single time. This even stands true for adults and will make the Cannabidiol treatment experience easier and more enjoyable to dose.
The CEO of Ubiquitech expressed that they are extremely delighted to be launching this product to their CannazALL brand, and it is an ideal complement to company’s other popular products.